Mullen Group Ltd.
Mullen Group Ltd. (MLLGF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Mullen Group Ltd. (MLLGF), covering cash flow, earnings, and balance sheets.
Mullen Group Ltd. (MLLGF) Income Statement & Financial Overview
Explore comprehensive income reports for Mullen Group Ltd. MLLGF, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $497.14M | $499.03M | $532.03M | $495.60M |
| Cost of Revenue | $389.50M | $385.46M | $399.79M | $372.93M |
| Gross Profit | $107.64M | $113.57M | $132.25M | $122.67M |
| Gross Profit Ratio | $0.22 | $0.23 | $0.25 | $0.25 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $73.78M | $64.04M | $71.92M | $69.88M |
| Operating Expenses | $73.79M | $64.04M | $71.92M | $69.88M |
| Total Costs & Expenses | $463.30M | $449.51M | $470.21M | $442.81M |
| Interest Income | $0.00 | $6.13M | $0.00 | $0.00 |
| Interest Expense | $11.46M | $16.81M | $12.19M | $10.18M |
| Depreciation & Amortization | $34.13M | $35.45M | $34.96M | $32.44M |
| EBITDA | $69.91M | $81.85M | $97.71M | $85.13M |
| EBITDA Ratio | $0.14 | $0.16 | $0.18 | $0.17 |
| Operating Income | $33.85M | $49.52M | $60.33M | $52.79M |
| Operating Income Ratio | $0.07 | $0.10 | $0.11 | $0.11 |
| Other Income/Expenses (Net) | -$9.15M | -$19.94M | -$9.77M | -$43.22M |
| Income Before Tax | $24.70M | $29.59M | $50.56M | $42.51M |
| Income Before Tax Ratio | $0.05 | $0.06 | $0.10 | $0.09 |
| Income Tax Expense | $6.97M | $10.76M | $12.21M | $10.92M |
| Net Income | $17.73M | $18.83M | $38.35M | $32.86M |
| Net Income Ratio | $0.04 | $0.04 | $0.07 | $0.07 |
| EPS | $0.20 | $0.15 | $0.46 | $0.37 |
| Diluted EPS | $0.20 | $0.14 | $0.41 | $0.34 |
| Weighted Avg Shares Outstanding | $87.65M | $87.85M | $87.70M | $88.00M |
| Weighted Avg Shares Outstanding (Diluted) | $87.83M | $97.23M | $97.04M | $97.09M |
Over the past four quarters, Mullen Group Ltd. demonstrated steady revenue growth, increasing from $495.60M in Q2 2024 to $497.14M in Q1 2025. Operating income reached $33.85M in Q1 2025, maintaining a consistent 7% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $69.91M, reflecting operational efficiency. Net income dropped to $17.73M, with EPS at $0.20. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan